CYNATA THERAPEUTICS LIMITED - Announcements

0.00%

19.0¢

Market Cap $45.11M

Healthcare Biotechnology

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

Recce Pharmaceuticals (ASX:RCE) eyes US Defence grants with early data for R327 on burn wounds

Announcements

Filter Results

All Price Sensitive Only

CYP	Appendix 4G		28/08/25	279.19KB	Share
CYP	Corporate Governance Statement		28/08/25	356.07KB	Share
CYP	Appendix 4E & Annual Report	PRICE SENSITIVE	28/08/25	2.23MB	Share
CYP	Change in substantial holding		26/08/25	258.15KB	Share
CYP	Cleansing Notice		22/08/25	251.47KB	Share
CYP	Application for quotation of securities - CYP		22/08/25	18.14KB	Share
CYP	At-the-Market Subscription Agreement	PRICE SENSITIVE	22/08/25	165.03KB	Share
CYP	Cynata to present at Bioshares Biotech Summit		07/08/25	2.69MB	Share
CYP	Investor Webinar		05/08/25	506.95KB	Share
CYP	June 2025 Quarterly Activity Report and Appendix 4C	PRICE SENSITIVE	30/07/25	302.04KB	Share
CYP	Notification regarding unquoted securities - CYP		10/06/25	24.6KB	Share
CYP	Proposed issue of securities - CYP		04/06/25	22.13KB	Share
CYP	InvestorHub Portal and New Website		22/05/25	153.94KB	Share
CYP	CYP-001s FDA Approval Pathway Not Impeded	PRICE SENSITIVE	16/05/25	161.82KB	Share
CYP	Investor Webinar		05/05/25	580.9KB	Share
CYP	March 2025 Quarterly Activity Report and Appendix 4C	PRICE SENSITIVE	24/04/25	404.91KB	Share
CYP	Australian Federal Government Announces Funding of SMART CRC		24/04/25	159.87KB	Share
CYP	Cynata Establishes New Scientific Advisory Board		14/04/25	170.29KB	Share
CYP	Promising Preclinical Heart Disease Data		07/04/25	183.27KB	Share
CYP	Appendix 3Ys x 4		01/04/25	250.77KB	Share
CYP	Cynata Presenting at Advanced Therapies Congress		18/03/25	2.49MB	Share
CYP	Cynata Participating in Euroz Hartleys Investor Conference		12/03/25	2.97MB	Share
CYP	Appendix 4D & Half-Year Financial Statements	PRICE SENSITIVE	27/02/25	852.38KB	Share
CYP	Expiry of listed CYPOA Options		27/02/25	151.69KB	Share
CYP	Appendix 3Y - Paul Wotton		20/02/25	188.94KB	Share
CYP	Application for quotation of securities - CYP		20/02/25	15.65KB	Share
CYP	Investor Webinar		06/02/25	1.36MB	Share
CYP	Publication comparing Cymerus MSCs to other MSCs	PRICE SENSITIVE	05/02/25	182.29KB	Share
CYP	Cynata to Present at Euroz Hartleys Healthcare Forum		04/02/25	2.24MB	Share
CYP	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	30/01/25	337.68KB	Share
CYP	Appendix 3Y x 5		23/01/25	275.39KB	Share
CYP	Cleansing Notice		23/01/25	221.47KB	Share
CYP	Application for quotation of securities - CYP		23/01/25	15.76KB	Share
CYP	Results of Meeting		21/01/25	262.41KB	Share
CYP	Cynata to Present at Biotech Showcase		13/01/25	12.96MB	Share
CYP	Change in substantial holding - Phillip Asset Management		31/12/24	165.27KB	Share
CYP	Letter to Shareholders, Notice of EGM & Proxy Form		20/12/24	526.96KB	Share
CYP	Cleansing Notice		16/12/24	221.62KB	Share
CYP	Application for quotation of securities - CYP		16/12/24	15.69KB	Share
CYP	First Kidney Transplant Trial Patient Treated	PRICE SENSITIVE	12/12/24	192.51KB	Share
CYP	Investor Webinar		10/12/24	146.18KB	Share
CYP	Proposed issue of securities - CYP		06/12/24	15.6KB	Share
CYP	Proposed issue of securities - CYP		06/12/24	15.71KB	Share
CYP	Cynata secures commitments for $8.1m institutional placement	PRICE SENSITIVE	06/12/24	182.05KB	Share
CYP	Demonstrated Safety & Efficacy in DFU Clinical Trial	PRICE SENSITIVE	05/12/24	2.37MB	Share
CYP	Trading Halt	PRICE SENSITIVE	04/12/24	321.74KB	Share
CYP	Cynata Receives $1.88m R&D Tax Incentive Refund	PRICE SENSITIVE	26/11/24	215.19KB	Share
CYP	Results of Annual General Meeting		19/11/24	269.34KB	Share
CYP	AGM Presentations		19/11/24	2.14MB	Share
CYP	Updated Investor Presentation		12/11/24	4.76MB	Share
CYP	Cleansing Notice		08/11/24	221.37KB	Share
CYP	Application for quotation of securities - CYP		08/11/24	15.8KB	Share
CYP	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	25/10/24	407.62KB	Share
CYP	Annual Report to Shareholders		18/10/24	5.74MB	Share
CYP	Letter to Shareholders, Notice of AGM & Proxy Form		18/10/24	856.6KB	Share
CYP	Alliance for Regenerative Medicine Meeting Presentation		08/10/24	2.48MB	Share
CYP	Notification regarding unquoted securities - CYP		01/10/24	23.75KB	Share
CYP	Proposed issue of securities - CYP		30/09/24	22.11KB	Share
CYP	Date of AGM and Closing Date for Director Nominations		24/09/24	178.55KB	Share
CYP	Notification of cessation of securities - CYP		16/09/24	12.92KB	Share
CYP	Notification regarding unquoted securities - CYP		13/09/24	17.16KB	Share
CYP	Investor Webinar Presentation		05/09/24	2.78MB	Share
CYP	Cleansing Notice		02/09/24	221.4KB	Share
CYP	Application for quotation of securities - CYP		02/09/24	15.97KB	Share
CYP	Investor Webinar		30/08/24	137.62KB	Share
CYP	Appendix 4G		29/08/24	287.83KB	Share
CYP	Corporate Governance Statement		29/08/24	357.96KB	Share
CYP	Appendix 4E & Annual Report	PRICE SENSITIVE	29/08/24	5.84MB	Share
CYP	Proposed issue of securities - CYP		19/08/24	15.21KB	Share
CYP	Appendix 3Y - Dr Kilian Kelly		19/08/24	190.66KB	Share
CYP	Notification of cessation of securities - CYP		19/08/24	12.92KB	Share
CYP	Cynata to Present at ISCT Meeting		09/08/24	3.08MB	Share
CYP	Study of Cymerus MSCs in Pulmonary Fibrosis Published	PRICE SENSITIVE	08/08/24	183.38KB	Share
CYP	Cleansing Notice		31/07/24	221.67KB	Share
CYP	Application for quotation of securities - CYP		31/07/24	15.87KB	Share
CYP	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	30/07/24	290.82KB	Share
CYP	Application for quotation of securities - CYP		19/07/24	15.63KB	Share
CYP	Cynata Presents at Bioshares Summit		12/07/24	3.48MB	Share
CYP	Proposed issue of securities - CYP		01/07/24	14.84KB	Share
CYP	Cynata to Acquire IP from Tekcyte	PRICE SENSITIVE	01/07/24	145.6KB	Share
CYP	Sharewise Investor Presentation		27/06/24	3.53MB	Share
CYP	CYP Presents at Major International Cell Therapy Conference		29/05/24	2.54MB	Share
CYP	Further GvHD Clinical Data Published in Nature Medicine	PRICE SENSITIVE	22/05/24	163.8KB	Share
CYP	Appendix 3Y-Dr Geoffrey Brooke		17/05/24	192.51KB	Share
CYP	Notification of cessation of securities - CYP		17/05/24	13.01KB	Share
CYP	Investor Presentation		07/05/24	3.3MB	Share
CYP	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	30/04/24	325.82KB	Share
CYP	Notification regarding unquoted securities - CYP		17/04/24	18.39KB	Share
CYP	DFU Clinical Trial Enrolment Complete	PRICE SENSITIVE	08/04/24	141.17KB	Share
CYP	EU Approval for Phase 2 CYP-001 Trial in GvHD	PRICE SENSITIVE	20/03/24	151.52KB	Share
CYP	Cynata Presenting at Advanced Therapies Congress		18/03/24	2.84MB	Share
CYP	First Patient Treated in Phase 2 GvHD Trial	PRICE SENSITIVE	05/03/24	154.43KB	Share
CYP	Cynata Appoints New Chief Business Officer		29/02/24	157.89KB	Share
CYP	Encouraging Initial Data from CYP-006TK DFU Trial	PRICE SENSITIVE	26/02/24	161.15KB	Share
CYP	Appendix 4D & Half-Year Financial Statements	PRICE SENSITIVE	23/02/24	828KB	Share
CYP	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	30/01/24	442.87KB	Share
CYP	Notification regarding unquoted securities - CYP		16/01/24	28.07KB	Share
CYP	Initial Results in First 16 DFU Patients Expected in Q1 2024		28/12/23	200.06KB	Share
CYP	Recruitment Completed in Phase 3 OA Clinical Trial	PRICE SENSITIVE	13/12/23	200.67KB	Share
CYP	Phase 2 Trial of CYP-001 in aGvHD Approved in Turkey	PRICE SENSITIVE	07/12/23	198.02KB	Share

CYP Appendix 4G
28/08/25		279.19KB	Share
CYP Corporate Governance Statement
28/08/25		356.07KB	Share
CYP Appendix 4E & Annual Report
28/08/25	PRICE SENSITIVE	2.23MB	Share
CYP Change in substantial holding
26/08/25		258.15KB	Share
CYP Cleansing Notice
22/08/25		251.47KB	Share
CYP Application for quotation of securities - CYP
22/08/25		18.14KB	Share
CYP At-the-Market Subscription Agreement
22/08/25	PRICE SENSITIVE	165.03KB	Share
CYP Cynata to present at Bioshares Biotech Summit
07/08/25		2.69MB	Share
CYP Investor Webinar
05/08/25		506.95KB	Share
CYP June 2025 Quarterly Activity Report and Appendix 4C
30/07/25	PRICE SENSITIVE	302.04KB	Share
CYP Notification regarding unquoted securities - CYP
10/06/25		24.6KB	Share
CYP Proposed issue of securities - CYP
04/06/25		22.13KB	Share
CYP InvestorHub Portal and New Website
22/05/25		153.94KB	Share
CYP CYP-001s FDA Approval Pathway Not Impeded
16/05/25	PRICE SENSITIVE	161.82KB	Share
CYP Investor Webinar
05/05/25		580.9KB	Share
CYP March 2025 Quarterly Activity Report and Appendix 4C
24/04/25	PRICE SENSITIVE	404.91KB	Share
CYP Australian Federal Government Announces Funding of SMART CRC
24/04/25		159.87KB	Share
CYP Cynata Establishes New Scientific Advisory Board
14/04/25		170.29KB	Share
CYP Promising Preclinical Heart Disease Data
07/04/25		183.27KB	Share
CYP Appendix 3Ys x 4
01/04/25		250.77KB	Share
CYP Cynata Presenting at Advanced Therapies Congress
18/03/25		2.49MB	Share
CYP Cynata Participating in Euroz Hartleys Investor Conference
12/03/25		2.97MB	Share
CYP Appendix 4D & Half-Year Financial Statements
27/02/25	PRICE SENSITIVE	852.38KB	Share
CYP Expiry of listed CYPOA Options
27/02/25		151.69KB	Share
CYP Appendix 3Y - Paul Wotton
20/02/25		188.94KB	Share
CYP Application for quotation of securities - CYP
20/02/25		15.65KB	Share
CYP Investor Webinar
06/02/25		1.36MB	Share
CYP Publication comparing Cymerus MSCs to other MSCs
05/02/25	PRICE SENSITIVE	182.29KB	Share
CYP Cynata to Present at Euroz Hartleys Healthcare Forum
04/02/25		2.24MB	Share
CYP Quarterly Activity Report & Appendix 4C
30/01/25	PRICE SENSITIVE	337.68KB	Share
CYP Appendix 3Y x 5
23/01/25		275.39KB	Share
CYP Cleansing Notice
23/01/25		221.47KB	Share
CYP Application for quotation of securities - CYP
23/01/25		15.76KB	Share
CYP Results of Meeting
21/01/25		262.41KB	Share
CYP Cynata to Present at Biotech Showcase
13/01/25		12.96MB	Share
CYP Change in substantial holding - Phillip Asset Management
31/12/24		165.27KB	Share
CYP Letter to Shareholders, Notice of EGM & Proxy Form
20/12/24		526.96KB	Share
CYP Cleansing Notice
16/12/24		221.62KB	Share
CYP Application for quotation of securities - CYP
16/12/24		15.69KB	Share
CYP First Kidney Transplant Trial Patient Treated
12/12/24	PRICE SENSITIVE	192.51KB	Share
CYP Investor Webinar
10/12/24		146.18KB	Share
CYP Proposed issue of securities - CYP
06/12/24		15.6KB	Share
CYP Proposed issue of securities - CYP
06/12/24		15.71KB	Share
CYP Cynata secures commitments for $8.1m institutional placement
06/12/24	PRICE SENSITIVE	182.05KB	Share
CYP Demonstrated Safety & Efficacy in DFU Clinical Trial
05/12/24	PRICE SENSITIVE	2.37MB	Share
CYP Trading Halt
04/12/24	PRICE SENSITIVE	321.74KB	Share
CYP Cynata Receives $1.88m R&D Tax Incentive Refund
26/11/24	PRICE SENSITIVE	215.19KB	Share
CYP Results of Annual General Meeting
19/11/24		269.34KB	Share
CYP AGM Presentations
19/11/24		2.14MB	Share
CYP Updated Investor Presentation
12/11/24		4.76MB	Share
CYP Cleansing Notice
08/11/24		221.37KB	Share
CYP Application for quotation of securities - CYP
08/11/24		15.8KB	Share
CYP Quarterly Activity Report & Appendix 4C
25/10/24	PRICE SENSITIVE	407.62KB	Share
CYP Annual Report to Shareholders
18/10/24		5.74MB	Share
CYP Letter to Shareholders, Notice of AGM & Proxy Form
18/10/24		856.6KB	Share
CYP Alliance for Regenerative Medicine Meeting Presentation
08/10/24		2.48MB	Share
CYP Notification regarding unquoted securities - CYP
01/10/24		23.75KB	Share
CYP Proposed issue of securities - CYP
30/09/24		22.11KB	Share
CYP Date of AGM and Closing Date for Director Nominations
24/09/24		178.55KB	Share
CYP Notification of cessation of securities - CYP
16/09/24		12.92KB	Share
CYP Notification regarding unquoted securities - CYP
13/09/24		17.16KB	Share
CYP Investor Webinar Presentation
05/09/24		2.78MB	Share
CYP Cleansing Notice
02/09/24		221.4KB	Share
CYP Application for quotation of securities - CYP
02/09/24		15.97KB	Share
CYP Investor Webinar
30/08/24		137.62KB	Share
CYP Appendix 4G
29/08/24		287.83KB	Share
CYP Corporate Governance Statement
29/08/24		357.96KB	Share
CYP Appendix 4E & Annual Report
29/08/24	PRICE SENSITIVE	5.84MB	Share
CYP Proposed issue of securities - CYP
19/08/24		15.21KB	Share
CYP Appendix 3Y - Dr Kilian Kelly
19/08/24		190.66KB	Share
CYP Notification of cessation of securities - CYP
19/08/24		12.92KB	Share
CYP Cynata to Present at ISCT Meeting
09/08/24		3.08MB	Share
CYP Study of Cymerus MSCs in Pulmonary Fibrosis Published
08/08/24	PRICE SENSITIVE	183.38KB	Share
CYP Cleansing Notice
31/07/24		221.67KB	Share
CYP Application for quotation of securities - CYP
31/07/24		15.87KB	Share
CYP Quarterly Activity Report & Appendix 4C
30/07/24	PRICE SENSITIVE	290.82KB	Share
CYP Application for quotation of securities - CYP
19/07/24		15.63KB	Share
CYP Cynata Presents at Bioshares Summit
12/07/24		3.48MB	Share
CYP Proposed issue of securities - CYP
01/07/24		14.84KB	Share
CYP Cynata to Acquire IP from Tekcyte
01/07/24	PRICE SENSITIVE	145.6KB	Share
CYP Sharewise Investor Presentation
27/06/24		3.53MB	Share
CYP CYP Presents at Major International Cell Therapy Conference
29/05/24		2.54MB	Share
CYP Further GvHD Clinical Data Published in Nature Medicine
22/05/24	PRICE SENSITIVE	163.8KB	Share
CYP Appendix 3Y-Dr Geoffrey Brooke
17/05/24		192.51KB	Share
CYP Notification of cessation of securities - CYP
17/05/24		13.01KB	Share
CYP Investor Presentation
07/05/24		3.3MB	Share
CYP Quarterly Activity Report & Appendix 4C
30/04/24	PRICE SENSITIVE	325.82KB	Share
CYP Notification regarding unquoted securities - CYP
17/04/24		18.39KB	Share
CYP DFU Clinical Trial Enrolment Complete
08/04/24	PRICE SENSITIVE	141.17KB	Share
CYP EU Approval for Phase 2 CYP-001 Trial in GvHD
20/03/24	PRICE SENSITIVE	151.52KB	Share
CYP Cynata Presenting at Advanced Therapies Congress
18/03/24		2.84MB	Share
CYP First Patient Treated in Phase 2 GvHD Trial
05/03/24	PRICE SENSITIVE	154.43KB	Share
CYP Cynata Appoints New Chief Business Officer
29/02/24		157.89KB	Share
CYP Encouraging Initial Data from CYP-006TK DFU Trial
26/02/24	PRICE SENSITIVE	161.15KB	Share
CYP Appendix 4D & Half-Year Financial Statements
23/02/24	PRICE SENSITIVE	828KB	Share
CYP Quarterly Activity Report & Appendix 4C
30/01/24	PRICE SENSITIVE	442.87KB	Share
CYP Notification regarding unquoted securities - CYP
16/01/24		28.07KB	Share
CYP Initial Results in First 16 DFU Patients Expected in Q1 2024
28/12/23		200.06KB	Share
CYP Recruitment Completed in Phase 3 OA Clinical Trial
13/12/23	PRICE SENSITIVE	200.67KB	Share
CYP Phase 2 Trial of CYP-001 in aGvHD Approved in Turkey
07/12/23	PRICE SENSITIVE	198.02KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 19.0¢		Change 0.000(0.00%)		Mkt cap ! $45.11M

Open	High	Low	Value	Volume
20.0¢	20.3¢	19.0¢	$73.42K	380.9K

Buyers (Bids)

No.	Vol.	Price($)
3	95351	18.5¢

Sellers (Offers)

Price($)	Vol.	No.
19.0¢	30328	1

View Market Depth

No.	Vol.	Price($)
3	95351	0.185
6	183749	0.180
4	135266	0.175
4	170886	0.170
3	90000	0.160

Price($)	Vol.	No.
0.190	30328	1
0.195	5128	1
0.205	184639	1
0.210	46840	2
0.215	10000	1

Last trade - 15.59pm 10/09/2025 (20 minute delay)

CYP (ASX) Chart

CYNATA THERAPEUTICS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories